Growing Market for Sequencing in U.S. and China, But Users Want Improvements

Kalorama Information publishes new report on the Next-Generation Sequencing market

The DNA sequencer market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future. In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. However, in the last three or four years, the market has become slightly more stable and a lot of the momentum has slowed. Kalorama surveys the market from time to time and also makes forecasts and projections.

This was the finding of Kalorama Information’s Next-Generation Sequencing Market and Kalorama Survey of NGS Laboratories. The report was both a secondary market analysis effort and a survey of laboratories. There is a 4 billion-dollar market for sequencing, according to Kalorama Information’s research. With a sizeable portion, over 12% of that demand in China.

The market research firm’s study aimed to identify some of the key trends taking place with both next-generation systems and capillary sequencers in relation to their usage in labs, and in relation to the sequencing of clinical samples for diagnostic or clinical research purposes.

The study focuses on a survey of 70 laboratories which was carried out from March to July of 2019. The survey effort targeted labs with some likelihood to be doing, or to be planning, applications of sequencing in either diagnostic or clinical research settings in the future. This is not straightforward to determine beforehand, as there are many different factors that drive a lab to consider diagnostics.

Among the findings of the survey: 

  • Most labs think their sequencing volume growth will grow between 1-20%. Resequencing/ targeted
  • mRNA-seq / transcriptome were among usages demonstrating an increase
  • MiSeq was the commonly owned model in the survey, followed by next Seq
  • Respondents want to reduce costs of systems first. The next priority is improving sample prep
  • Library preparation remains a key concern of labs, a key bottleneck.

Customers also revealed purchasing plans and bottleneck areas where they’d like improvements. Scores of questions were addressed in the report. Kalorama’s report is available at:

About Kalorama Information


For more than 30 years, Kalorama Information has been a leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), imaging, biotechnology, healthcare, medical devices, and pharmaceuticals.

Kalorama Information Logo